The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Open accessAbstract
The liver is the most common site of metastatic disease 1. Although this metastatic tropism may reflect the mechanical trapping of circulating tumour cells, liver metastasis is also dependent, at least in part, on the formation of a 'pro-metastatic' niche that supports the spread of tumour cells to the liver 2,3. The mechanisms that direct the formation of this niche are poorly understood. Here we show that hepatocytes coordinate myeloid cell accumulation and fibrosis within the liver and, in doing so, increase the susceptibility of the liver to metastatic seeding and outgrowth. During early pancreatic tumorigenesis in mice, hepatocytes show activation of signal transducer and activator of transcription 3 (STAT3) signalling and increased production of serum amyloid A1 and A2 (referred to collectively as SAA). Overexpression of SAA by hepatocytes also occurs in patients with pancreatic and colorectal cancers that have metastasized to the liver, and many patients with locally advanced and metastatic disease show increases in circulating SAA. Activation of STAT3 in hepatocytes and the subsequent production of SAA depend on the release of interleukin 6 (IL-6) into the circulation by non-malignant cells. Genetic ablation or blockade of components of IL-6-STAT3-SAA signalling prevents the establishment of a pro-metastatic niche and inhibits liver metastasis. Our data identify an intercellular network underpinned by hepatocytes that forms the basis of a pro-metastatic niche in the liver, and identify new therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Markedly, in mouse fetal livers, STAT3 was not activated (Figure S6D) and canonical STAT3 target genes 31,32 were not induced (Figure S6E).”
From Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers (2023) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Primer3—new capabilities and interfaces
Untergasser, A., Cutcutache, I., Kõressaar, T., Ye, J., Faircloth, B., Remm, M., & Rozen, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks596 · Cited by 9,165
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., Fridman, W.-H., Pagès, F., Trajanoski, Z., & Galon, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp101 · Cited by 6,280
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Cited by
Sorted by citations
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,536
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level
Wu, Y., Yang, S., Ma, J., Chen, Z., Song, G., Rao, D., Cheng, Y., Huang, S., Liu, Y., Jiang, S., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0316 · Cited by 1,238
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Hosein, A. N., Brekken, R. A., & Maitra, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0300-1 · Cited by 950
Gerstberger, S. C., Jiang, Q., & Ganesh, K. (2023) · Cell · doi:10.1016/j.cell.2023.03.003 · Cited by 1,010
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D. R., Seehawer, M., Zender, L., & Heikenwälder, M. F. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 639
Bertocchi, A., Carloni, S., Ravenda, P. S., Bertalot, G., Spadoni, I., Lo Cascio, A., Gandini, S., Lizier, M., Braga, D., Asnicar, F., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.004 · Cited by 515
Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer
Buechler, M. B., Fu, W., & Turley, S. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.021 · Cited by 494
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Sherman, M. H., & Beatty, G. L. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031621-024600 · Cited by 501
Self-citationSerum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Lee, J., Hall, J. A., Kroehling, L., Wu, L., Najar, T. A., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.11.026 · Cited by 476
Self-citationSystems Biology of Cancer Metastasis
Suhail, Y., Cain, M. P., Vanaja, K. G., Kurywchak, P. A., Levchenko, A., Kalluri, R., & Gupta, K. (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.003 · Cited by 474
Activated fibroblasts in cancer: Perspectives and challenges
Caligiuri, G., & Tuveson, D. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.015 · Cited by 450
Sleeboom, J. J. F., van Tienderen, G. S., Schenke‐Layland, K., van der Laan, L. J. W., Khalil, A., & Verstegen, M. M. A. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg3840 · Cited by 401
Metastasis Organotropism: Redefining the Congenial Soil
Gao, Y., Bado, I., Wang, H., Zhang, W., Rosen, J. M., & Zhang, X. H.-F. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.012 · Cited by 395
Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
Correia, A. L., Guimaraes, J. C., Auf der Maur, P., De Silva, D., Trefny, M. P., Okamoto, R., Bruno, S., Schmidt, A., Mertz, K., Volkmann, K., et al. (2021) · Nature · doi:10.1038/s41586-021-03614-z · Cited by 339
Microenvironmental Determinants of Pancreatic Cancer
Heßmann, E., Buchholz, S., Demir, İ. E., Singh, S. K., Gress, T. M., Ellenrieder, V., & Neeße, A. (2020) · Physiological Reviews · doi:10.1152/physrev.00042.2019 · Cited by 336
Zou, Y., Ye, F., Kong, Y., Hu, X., Deng, X., Xie, J., Song, C., Ou, X., Wu, S., Wu, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202203699 · Cited by 285
Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
Tuomisto, A., Mäkinen, M. J., & Väyrynen, J. P. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4383 · Cited by 285
Ji, Q., Zhou, L., Sui, H. X., Yang, L., Wu, X., Song, Q., Jia, R., Li, R., Sun, J., Wang, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14869-x · Cited by 273
Pre-metastatic niche: formation, characteristics and therapeutic implication
Wang, Y., Jia, J., Wang, F., Fang, Y., Yang, Y., Zhou, Q., Yuan, W., Gu, X., Hu, J., & Yang, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01937-7 · Cited by 289
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Li, Y., Liu, F., Cai, Q., Deng, L., Ouyang, Q., Zhang, X. H.-F., & Zheng, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02148-4 · Cited by 314
Ceci, C., Atzori, M. G., Lacal, P. M., & Graziani, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041388 · Cited by 256
Wu, L. L., Yan, J., Bai, Y., Chen, F., Zou, X., Xu, J., Huang, A., Hou, L., Zhong, Y., Jing, Z., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00831-1 · Cited by 253
Immune determinants of the pre-metastatic niche
Pătraș, L., Shaashua, L., Matei, I. R., & Lyden, D. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.018 · Cited by 229
Metastatic-niche labelling reveals parenchymal cells with stem features
Ombrato, L., Nolan, E., Kurelac, I., Mavousian, A., Bridgeman, V. L., Heinze, I., Chakravarty, P., Horswell, S. D., González‐Gualda, E., Matacchione, G., et al. (2019) · Nature · doi:10.1038/s41586-019-1487-6 · Cited by 205
Self-citationGenetically engineered myeloid cells rebalance the core immune suppression program in metastasis
Kaczanowska, S., Beury, D. W., Gopalan, V., Tycko, A. K., Qin, H., Clements, M. E., Drake, J. A., Nwanze, C., Murgai, M., Rae, Z., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.048 · Cited by 208
Understanding cachexia in the context of metastatic progression
Biswas, A., & Acharyya, S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0251-4 · Cited by 199
Yang, Y., Li, S., To, K. K. W., Zhu, S., Wang, F., & Fu, L. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03377-9 · Cited by 221
Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
Geng, X., Chen, H., Zhao, L., Hu, J., Yang, W., Li, G., Cheng, C., Zhao, Z., Zhang, T., Li, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.655152 · Cited by 202
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Lin, J. H., Huffman, A. P., Wattenberg, M. M., Walter, D. M., Carpenter, E. L., Feldser, D. M., Beatty, G. L., Furth, E. E., & Vonderheide, R. H. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190673 · Cited by 175
Self-citationThe Role of Metabolic Syndrome in Endometrial Cancer: A Review
Yang, X., & Wang, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00744 · Cited by 168
The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis
Kobayashi, H., Gieniec, K. A., Wright, J. A., Wang, T., Asai, N., Mizutani, Y., Lida, T., Ando, R., Suzuki, N., Lannagan, T. R. M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.011 · Cited by 158
Gan, S., Tong, X., Zhang, Y., Wu, J., Hu, Y., & Yuan, A. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902757 · Cited by 152
Serum Amyloid A (SAA) Proteins
Sack, G. H. (2020) · Subcellular Biochemistry · doi:10.1007/978-3-030-41769-7_17 · Cited by 149
Chen, X., & Song, E. (2022) · 癌症：英文版 · doi:10.1002/cac2.12316 · Cited by 151
Hypoxia‐Inducible Exosomes Facilitate Liver‐Tropic Premetastatic Niche in Colorectal Cancer
Sun, H., Meng, Q., Shi, C., Yang, H., Li, X., Wu, S., Familiari, G., Relucenti, M., Aschner, M., Wang, X., et al. (2021) · Hepatology · doi:10.1002/hep.32009 · Cited by 144
TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer
Schoeps, B., Eckfeld, C., Prokopchuk, O., Böttcher, J. P., Häußler, D., Steiger, K., Demir, İ. E., Knolle, P. A., Soehnlein, O., Jenne, D. E., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4125 · Cited by 141
The biological underpinnings of therapeutic resistance in pancreatic cancerPreprint
Beatty, G. L., Werba, G., Lyssiotis, C. A., & Simeone, D. M. (2021) · Genes & Development · doi:10.1101/gad.348523.121 · Cited by 139
Self-citationLi, L., Cui, L., Lin, P., Liu, Z., Bao, S., Ma, X., Nan, H., Zhu, W., Cen, J., Mao, Y., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.01.009 · Cited by 134
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages
Kemp, S. B., Steele, N. G., Carpenter, E. S., Donahue, K. L., Bushnell, G. G., Morris, A. H., The, S., Orbach, S. M., Sirihorachai, V. R., Nwosu, Z. C., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000935 · Cited by 129
Self-citationHuman biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117
Wang, Y., Zhong, X., He, X., Hu, Z., Huang, H., Chen, J., Chen, K., Zhao, S., Wei, P., & Li, D. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02729-7 · Cited by 131
Why is pancreatic cancer so deadly? The pathologist's view
Hruban, R. H., Gaida, M. M., Thompson, E., Hong, S., Noë, M., Brosens, L. A., Jongepier, M., Offerhaus, G. J. A., & Wood, L. D. (2019) · The Journal of Pathology · doi:10.1002/path.5260 · Cited by 115
Cancer Extracellular Matrix Proteins Regulate Tumour Immunity
Gordon-Weeks, A. N., & Yuzhalin, A. E. (2020) · Cancers · doi:10.3390/cancers12113331 · Cited by 121
Lee, B. Y., Hogg, E. K. J., Below, C., Kononov, A., Blanco‐Gómez, A., Heider, F., Xu, J., Hutton, C., Zhang, X. M., Scheidt, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27607-8 · Cited by 115
High-Density Lipoproteins and Serum Amyloid A (SAA)
Webb, N. R. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00901-4 · Cited by 103
Self-citationBellomo, G., Rainer, C., Quaranta, V., Astuti, Y., Raymant, M., Boyd, E., Stafferton, R., Campbell, F., Ghaneh, P., Halloran, C. M., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325272 · Cited by 102
Truong, L.-H., & Pauklin, S. (2021) · Cancers · doi:10.3390/cancers13195028 · Cited by 102
The immune microenvironment of colorectal cancer
Kennel, K. B., & Greten, F. R. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00872-1 · Cited by 122
EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells
Rodríguez-Aznar, E., Wiesmüller, L., Sáinz, B., & Hermann, P. C. (2019) · Cancers · doi:10.3390/cancers11081136 · Cited by 99
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Lee, J., Hall, J. A., Kroehling, L., Wu, L., Najar, T. A., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.12.008 · Cited by 95
Self-citationVaish, U., Jain, T., Are, A. C., & Dudeja, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413408 · Cited by 102
Baer, J. M., Zuo, C., Kang, L., de la Lastra, A. A., Borcherding, N. C., Knolhoff, B. L., Bogner, S. J., Zhu, Y., Yang, L., Poursine‐Laurent, J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-023-01579-x · Cited by 104
Jinesh, G. G., & Brohl, A. S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01132-6 · Cited by 96
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Stone, M. L., & Beatty, G. L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.012 · Cited by 87
Self-citationGautam, S. K., Batra, S. K., & Jain, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01813-y · Cited by 93
The hormetic and hermetic role of IL-6
Forcina, L., Franceschi, C., & Musarò, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101697 · Cited by 85
Liver Tropism in Cancer: The Hepatic Metastatic NichePreprint
Mielgo, A., & Schmid, M. C. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037259 · Cited by 86
The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases
Wang, M.-J., Zhang, H.-L., Chen, F., Guo, X.-J., Liu, Q.-G., & Hou, J. (2024) · Experimental Hematology & Oncology · doi:10.1186/s40164-024-00527-1 · Cited by 84
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Huang, C., Bian, A., Yang, L.-F., Yin, X., Wang, J., Ti, C., Miao, Y., Peng, S., Xu, S., Liu, M., et al. (2021) · Oncogene · doi:10.1038/s41388-020-01626-z · Cited by 84
Alonso‐Nocelo, M., Ruíz-Cañas, L., Sancho, P., Görgülü, K., Alcalá, S., Pedrero, C., Vallespinós, M., López-Gil, J. C., Ochando, M., García-García, E., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325564 · Cited by 86
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target
Ma, C., Zhang, Q., & Greten, T. F. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104295 · Cited by 79
Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
Wang, H., Pan, J., Barsky, L., Jacob, J. C., Zheng, Y., Gao, C., Wang, S., Zhu, W., Sun, H., Lu, L., et al. (2021) · Molecular Biomedicine · doi:10.1186/s43556-020-00022-z · Cited by 81
Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
Pereira, M. A., & Chio, I. I. C. (2019) · Genes · doi:10.3390/genes11010006 · Cited by 75
Cheng, Y., Chen, X., Li, F., Yang, Z., Xiao, L., Xiang, B., Wang, X., Liu, D., Lin, P., Shi, J.-Y., et al. (2025) · Cell Discovery · doi:10.1038/s41421-024-00747-z · Cited by 80
Self-citationLi, S., Xia, H., Wang, Z., Zhang, X., Song, T., Li, J., Xu, L., Zhang, N., Fan, S., Li, Q., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000427 · Cited by 74
Self-citationFunctional heterogeneity of fibroblasts in primary tumors and metastases
Cheng, P. S. W., Zaccaria, M., & Biffi, G. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.11.005 · Cited by 78
Jiang, T., Chen, L., Huang, Y., Wang, J., Xu, M., Zhou, S., Gu, X. Q., Chen, Y., Liang, K., Pei, Y., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00495 · Cited by 69
Pellinen, T. S., Paavolainen, L., Martín-Bernabé, A., Araujo, R. P., Strell, C., Mezheyeuski, A., Backman, M., Fleur, L. L., Brück, O. E., Sjölund, J., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac178 · Cited by 67
Zhuyan, J., Chen, M., Zhu, T., Bao, X., Zhen, T., Xing, K., Wang, Q., & Zhu, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00453-9 · Cited by 69
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway
Swoboda, A., Soukup, R., Eckel, O., Kinslechner, K., Wingelhofer, B., Schörghofer, D., Sternberg, C., Pham, H. T. T., Vallianou, M., Horvath, J., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01584-6 · Cited by 63
Improving outcomes of patients with pancreatic cancer
Dreyer, S. B., Beer, P. A., Hingorani, S. R., & Biankin, A. V. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01019-9 · Cited by 71
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 86
Glioma-derived exosomes hijack the blood–brain barrier to facilitate nanocapsule delivery via LCN2
Yang, C., Wu, Y., Wang, L., Li, S., Zhou, J., Tan, Y., Song, J. L., Xing, H., Yi, K., Zhan, Q., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.038 · Cited by 61
Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer
Kemp, S. B., di Magliano, M. P., & Crawford, H. C. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.006 · Cited by 64
Local and systemic effects of interleukin‐6 (IL‐6) in inflammation and cancer
Rose‐John, S. (2021) · FEBS Letters · doi:10.1002/1873-3468.14220 · Cited by 59
Hepatic lipids promote liver metastasis
Li, Y., Su, X., Rohatgi, N., Zhang, Y., Brestoff, J. R., Shoghi, K. I., Xu, Y., Semenkovich, C. F., Harris, C. A., Peterson, L. L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136215 · Cited by 57
Dixit, A. K., Sarver, A. G., Zettervall, J., Huang, H., Zheng, K., Brekken, R. A., & Provenzano, P. P. (2022) · JCI Insight · doi:10.1172/jci.insight.153242 · Cited by 61
The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
Ohara, Y., Valenzuela, P., & Hussain, S. P. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.004 · Cited by 54
Decoding the interplay between genetic and non-genetic drivers of metastasis
Karras, P., Black, J. R., McGranahan, N., & Marine, J. (2024) · Nature · doi:10.1038/s41586-024-07302-6 · Cited by 60
The Tumor Microenvironment of Colorectal Cancer Metastases: Opportunities in Cancer Immunotherapy
Kamal, Y., Schmit, S. L., Frost, H. R., & Amos, C. I. (2020) · Immunotherapy · doi:10.2217/imt-2020-0026 · Cited by 56
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1
Wattenberg, M. M., Coho, H., Herrera, V. M., Graham, K. L., Stone, M. L., Xue, Y., Chang, R. B., Cassella, C. R., Liu, M., Choi-Bose, S., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adj5097 · Cited by 53
Self-citationOvercoming immunotherapeutic resistance by targeting the cancer inflammation cycle
Wattenberg, M. M., & Beatty, G. L. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.002 · Cited by 54
Self-citationIncidence and prognosis of liver metastasis at diagnosis: a pan-cancer population-based study.
Wang, S., Feng, Y., Swinnen, J. V., Oyen, R., Li, Y., & Ni, Y. (2020) · PubMed Central · Cited by 53
TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer
Hermann, C. D., Schoeps, B., Eckfeld, C., Munkhbaatar, E., Kniep, L., Prokopchuk, O., Wirges, N., Steiger, K., Häußler, D., Knolle, P. A., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210911 · Cited by 55
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Schmiechen, Z. C., & Stromnes, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613815 · Cited by 56
Organ tropism in solid tumor metastasis: an updated review.
Mortezaee, K. (2021) · Future Oncology · doi:10.2217/fon-2020-1103 · Cited by 49
Immune cell shuttle for precise delivery of nanotherapeutics for heart disease and cancer
Huang, S.-S., Lee, K., Chen, H.-C., Prajnamitra, R. P., Hsu, C., Jian, C., Yu, X.-E., Chueh, D., Kuo, C. W., Chiang, T., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf2400 · Cited by 51
He, M., Liu, Y., Chen, S., Deng, H., Feng, C., Qiao, S., Chen, Q., Hu, Y., Chen, H., Wang, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46118-w · Cited by 52
Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells
Rabas, N., Ferreira, R. M. M., Blasio, S. D., & Malanchi, I. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00752-0 · Cited by 58
Xie, L., Qiu, S., Chen, L., Gu, C., Wang, J., Lv, J., Fang, L., Chen, Z., Li, Y., Jiang, T., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02833-8 · Cited by 51
Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers
Shalapour, S., & Karin, M. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082019-081656 · Cited by 52
TGF‐β signaling in liver metastasis
Marvin, D. L., Heijboer, R., ten Dijke, P., & Ritsma, L. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.160 · Cited by 53
Mechanisms of colorectal liver metastasis development
Shasha, T., Gruijs, M., & van Egmond, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04630-6 · Cited by 51
Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice
Thomas, S. K., Wattenberg, M. M., Choi-Bose, S., Uhlik, M. T., Harrison, B., Coho, H., Cassella, C. R., Stone, M. L., Patel, D. G., Markowitz, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41771-z · Cited by 51
Self-citationCell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis
Zeng, X., Zhou, J., Xiong, Z., Sun, H., Yang, W., Mok, M. T. S., Wang, J., Li, J., Liu, M., Tang, W., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00534-2 · Cited by 50
Self-citationHuang, C., Zhou, W., Bian, A., Zhang, Q., Miao, Y., Yin, X., Ye, J., Xu, S., Ti, C., Sun, Z., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0997 · Cited by 50
Metadata
- Authors
- Lee, J. W., Stone, M. L., Porrett, P. M., Thomas, S. K., Komar, C. A., Li, J. H., Delman, D., Graham, K., Gladney, W. L., Hua, X., Black, T. A., Chien, A. L., Majmundar, K. S., Thompson, J. C., Yee, S. S., O’Hara, M. H., Aggarwal, C., Xin, D., Shaked, A., Gao, M., Liu, D., Borad, M. J., Ramanathan, R. K., Carpenter, E. L., Ji, A., de Beer, M. C., de Beer, F. C., Webb, N. R., & Beatty, G. L.
- Affiliations
- Abramson Cancer Center (US)
- University of Pennsylvania (US)
- University of Georgia (US)
- Mayo Clinic Comprehensive Cancer Center (Arizona) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Kentucky (US)
- Corresponding author
- Beatty, Gregory L.
- ORCID
- Lee, Jae W.
- Stone, Meredith L.
- Porrett, Paige M.
- Thomas, Stacy K.
- Li, Joey H.
- Graham, Kathleen
- Gladney, Whitney L.
- Chien, Austin L.
- Thompson, Jeffrey C.
- Yee, Stephanie S.
- O’Hara, Mark H.
- Aggarwal, Charu
- Xin, Dong
- Shaked, Abraham
- Gao, Mingming
- Liu, Dexi
- Borad, Mitesh J.
- Carpenter, Erica L.
- Ji, Ailing
- de Beer, Maria C.
- de Beer, Frederick C.
- Webb, Nancy R.
- Beatty, Gregory L.
- Venue
- Nature
- Published
- 2019-03-06
- Volume
- 567
- Issue
- 7747
- Pages
- 249-252
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6430113
- OpenAlex
- W2919508314
- Cited by
- 402
- References
- 41
- Citations by year
- 2026: 30 · 2025: 55 · 2024: 55 · 2023: 64 · 2022: 54 · 2021: 58 · 2020: 57 · 2019: 26
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Pennsylvania
- National Heart, Lung, and Blood Institute (R01HL134731, T32HL007439)
- National Cancer Institute (T32CA009140, F30CA196106, R01CA197916, P30CA016520)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050306)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- liver metastasis, hepatocytes, STAT3 signaling, serum amyloid A, interleukin-6, pancreatic cancer, colorectal cancer, liver fibrosis, tumor microenvironment, metastatic tropism
- MeSH terms
- Serum Amyloid A Protein, Animals, Female, Liver, Liver Neoplasms, Male, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Interleukin-6, Carcinoma, Pancreatic Ductal, Hepatocytes, STAT3 Transcription Factor, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
